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AbsTrACT
background/aims To assess response to real-world 
mobility scenarios in people with dry age-related macular 
degeneration (AMD) using a computer-based test.
Methods Participants were shown 18 point-of-view 
computer-based movies simulating walking through 
real-world scenarios, and pressed a button during 
scenes which would cause them self-perceived anxiety 
or concern in their day-to-day life. Button pressure was 
recorded throughout. Pressure traces were generated, 
which aligned with each movie time point. Group 
averages based on AMD severity were generated. 
Bootstrapped confidence intervals (CIs) for responses 
by group were generated around traces. Traces were 
examined to discover events causing the greatest 
differences between groups.
results Participants had early/no AMD (n=8), 
intermediate AMD (n=7) or geographic atrophy (n=15 
(GA)). Median (IQR) logMAR visual acuity was 0.04 
(−0.04, 0.18), 0.26 (0.10, 0.40) and 0.32 (0.20, 0.56), 
respectively. Participants with intermediate AMD or GA 
recorded greater pressure than those with early and no 
AMD (Kruskal-Wallis, p=0.04). Four events involving 
navigating stairs and three under low luminance elicited 
greatest differences between groups (p<0.001).
Conclusion People with intermediate AMD or GA likely 
experience higher levels of concern associated with 
mobility. The test highlights areas of specific concern. 
Results should be useful in patient management and 
educating the public about the everyday effects of AMD.
InTroduCTIon
Mobility, specifically physical activity, such as 
walking, is crucial for well-being. Increased 
mobility is related to improved physical and mental 
health,1 2 while decreased mobility is associated 
with poor health, social isolation and depression.3 
Lack of mobility may result in frailty, contributing 
to a vicious cycle of ill-health and immobility.4 
Age-related macular degeneration (AMD) is known 
to impact negatively on mobility. A recent system-
atic review5 reported mobility as the most frequent 
subject of published studies on visual disability in 
AMD. However, only two studies6 7 focused specif-
ically on people with non-neovascular (or dry) 
AMD, while one other8 considered AMD type in its 
analysis. Given the substantially higher prevalence 
of dry AMD as compared with neovascular AMD 
(nAMD), there is a clear gap in the literature on 
mobility in dry AMD.
One way of assessing physical mobility is through 
self-report. For example, self-report has been used 
to explore the effects of AMD on fall rates9 and fear 
of falling.10 Another approach involves mobility 
tasks in a lab-based setting, for example, navigating 
an obstacle course.11 In one study, eye movements 
and pupil diameter were measured while partici-
pants watched a movie of a journey while indicating 
sections of the journey deemed to be difficult.12 
Another method of assessing mobility is in the 
‘real-world’, for example, measuring road-crossing 
behaviour in the street13 or via cellular tracking 
devices.14 While these studies provide useful infor-
mation, one aspect of mobility that has had little 
attention in the AMD literature is anxiety and 
concern surrounding mobility. This may present a 
barrier to mobility tasks, resulting in consequences 
of decreased mobility described above.
The aim of this study was to assess distress asso-
ciated with mobility situations in people with dry 
AMD, in a safe environment simulating real-life 
mobility scenarios, using a novel computer-based 
test. In particular, we aimed to determine the 
effect of AMD severity, and to assess which types 
of mobility situations cause the greatest response 
among people with dry AMD. A secondary aim was 
to explore potential predictors of self-perceived 
concern/anxiety related to mobility.
MeThods
People with dry AMD were recruited from Moor-
fields Eye Hospital Trust, London, through optom-
etrists local to the university and through the 
Macular Society ( www. macularsociety. org). AMD 
participants were required to be aged ≥60 years, 
have sufficiently clear ocular media (Lens Opac-
ities Classification System (LOCS) III grade<3), 
adequate pupillary dilation and fixation to allow 
quality fundus imaging, and have dry AMD in their 
better-seeing eye. Fellow eyes could be of any AMD 
status. Binocular visual acuity (VA) was required 
to be logMAR 0.7 or better (Snellen equivalent of 
6/30) using an Early Treatment Diabetic Retinop-
athy Study (ETDRS) chart. Exclusion criteria were 
nAMD in the better-seeing eye, ocular or systemic 
diseases that could affect visual function or history 
of medication known to affect macular function, or 
high risk of angle closure during pupillary dilation. 
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Figure 1 Photographs of big button test setup.
Figure 2 Still screenshots from each of the 18 movies.
Participants were required to pass an abridged version of the 
Mini-Mental State Evaluation15 and have sufficient knowledge 
of the English language to understand the Participant Infor-
mation Sheet, undergo history and symptoms questioning and 
understand instructions.
Visually healthy controls were recruited from the City Sight 
Optometry Clinic at City, University of London. Eligibility 
criteria were same as for people with AMD except participants 
were required to have no AMD (or other eye diseases) in either 
eye, and monocular VA of logMAR 0.3 (6/12) or better in each 
eye.
The study was approved by Nottingham 2 National Health 
Service (NHS) Research Ethics Committee and was conducted 
according to the tenets of the Declaration of Helsinki. Written, 
informed consent was obtained from each participant prior to 
examination. Participant information was anonymised before 
being entered into a secure computer database.
Participants underwent baseline examinations to evaluate 
AMD status and ensure eligibility. Structured history and symp-
toms were taken including the EQ-5D questionnaire16 to assess 
health-related quality of life (HRQoL). Best corrected logMAR 
VA was determined with subjective refraction using an ETDRS 
chart. Contrast sensitivity (CS) was tested with a Pelli-Robson 
chart at 1 metre (binocularly) with best-corrected distance 
prescription and recorded as logCS.
Following study tests, participants underwent dilated fundus 
examination. Lens clarity was graded (LOCS III grading scale). 
Digital colour fundus photographs were obtained and used to 
classify and grade AMD status by the better-seeing eye (deter-
mined by VA) as early, intermediate or late according to the 
Beckman classification scale.17 Spectral-domain optical coher-
ence tomography (OCT) and fundus autofluorescence images 
were taken; these, along with slit lamp indirect ophthalmos-
copy, were used to support results obtained using colour fundus 
photographs, for example, OCT to confirm the presence of 
nAMD, or fundus autofluorescence to confirm the presence of 
GA.
Microperimetry was performed using the MAIA micrope-
rimeter (CenterVue, Padova, Italy). A total of 37 points were 
tested over the central 10° of the retina, measured using white 
Goldmann III targets presented for 200 ms, and thresholds were 
calculated using the system’s full threshold 4–2 staircase strategy.
experimental procedure
Participants were seated 50 cm away from a Dell 23-inch 
touch monitor—P2314T (resolution 1920×1080). Partici-
pants were tested binocularly wearing habitual intermediate 
correction. A box with a big button (BB) on the top was set in 
front of the monitor. This contained a custom-built force plate 
(capable of detectingcontinuous variations in pressure), which 
was interfaced using an Arduino Microcontroller (http://www. 
arduino. cc/). The test consisted of 18 short movies, shown in a 
randomised order. These were filmed from the point of view of 
someone walking through different real-world scenarios using 
a GoPro Hero4 camera mounted on a Feiyu Tech G4 3-Axis 
Handheld Steady Gimbal. The movie clips covered a range of 
walking settings, including light and dark conditions, indoor and 
outdoor, and rural and urban. Each of the movies showed situa-
tions which may induce anxiety for a person with visual impair-
ment. Scenarios included walking up and down stairs, walking 
around a museum, crossing roads, handling money and walking 
around a supermarket. The content was chosen based on our 
previous systematic review5 and interviews with individuals with 
dry AMD.
Test duration was 30 min (movie clips lasted between 29 and 
188 s; average duration 80 s). Participants were instructed to 
press down on the button with their dominant hand whenever 
they felt the footage to show a situation which would cause them 
anxiety or concern and to keep the button pressed until they felt 
that the situation had passed. Pressure on the BB was recorded 
throughout and quantified at each time point on a scale of 0 
(no pressure) to −1 (fully pressed). A demonstration in which 
a cartoon face appeared to smile when the BB was unpressed, 
frown when the BB was fully pressed and appeared neutral when 
the BB was semi-pressed was shown at the start of the test and 
in between each of the trials. Participants were asked to press 
the button 10 times each time they viewed the demonstration 
screen. This was used to assess whether differences in mean pres-
sure were apparent between groups while not watching a movie 
(due to muscle weakness or frailty). Setup of the experimental 
procedure with the demonstration screen and one of the test 
movies are shown in figure 1 and still screenshots from each of 
the 18 movies are shown in figure 2.
data analysis
Mean BB pressure across all movies was the primary outcome 
measure (BB response). Participants were grouped by AMD 
severity based on the Beckman classification17 in their better-
seeing eye. The distribution of pressure data was skewed so 
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Table 1 Summary of clinical measures expressed as median (IQR)
Controls
(early and no AMd, n=8)
Intermediate AMd
(n=7)
GA
(n=15) P value
Age, years 77 (72, 80) 82 (70, 86) 75 (70, 78) 0.20
Binocular VA 0.04 (−0.04, 0.18) 0.26 (0.10, 0.40) 0.32 (0.20, 0.56) 0.01
Better eye VA 0.10 (0.00, 0.18) 0.26 (0.20, 0.42) 0.36 (0.32, 0.60) <0.01
Worse eye VA 0.28 (0.06, 0.42) 0.58 (0.26, 1.58) 0.86 (0.40, 1.02) 0.01
CS 1.95 (1.65, 1.95) 1.60 (1.35, 1.65) 1.60 (1.25, 1.65) 0.01
Better eye AT 27.8 (26.1, 29.8) 26.5 (25.8, 27.8) 23.4 (19.0, 25.6) <0.01
Worse eye AT 27.0 (25.6, 29.5) 25.0 (23.8, 27.4) 20.4 (6.9, 23.8) <0.01
EQ-5D index score 0.89 (0.72, 1.00) 0.81 (0.72, 1.00) 0.77 (0.72, 1.00) 0.57
P values for between-group differences were calculated using Kruskal-Wallis tests.
AMD, age-related macular degeneration; AT, MAIA microperimetry average threshold; CS, Pelli-Robson contrast sensitivity (logCS);GA, geographic atrophy; VA, visual acuity 
(logMAR).
Figure 3 Mean big button response across all movies stratified by 
AMD classification (points have been horizontally jittered to avoid 
overlap). AMD, age-related macular degeneration; GA, geographic 
atrophy.
Kruskal-Wallis tests were used to test for differences between 
groups. Relationship between BB response and HRQoL was 
assessed by grouping participants according to their EQ-5D 
responses and testing for differences between these groups. 
Univariate associations (Spearman’s rho) between mean BB 
response and age, VA (better eye, worse eye and binocular), CS 
and average retinal sensitivity threshold (better eye and worse 
eye) as measured by microperimetry were explored.
The test generates a pressure trace that is aligned with time 
points throughout the movies to estimate the response at each 
moment. The trace can be derived such that it is an average from 
a group of participants. Bootstrapping was used to compute 
CIs for the meanresponse of each group around these traces 
(N=20 000; bias-corrected and accelerated method). Traces 
were examined to discover which types of mobility situations 
caused greatest differences between people with dry AMD and 
controls. Statistical analysis was carried out using SPSS Statistics 
V.22 and MATLAB R2016b (The Mathworks, Natick, Massa-
chusetts, USA).
resulTs
A total of 30 participants completed the BB test (n=5 no AMD, 
n=3 early AMD, n=7 intermediate AMD and n=15 GA) 
between March 2016 and March 2017. Visual function and 
demographic characteristics are presented in table 1. All visual 
function parameters differed significantly between groups based 
on AMD severity; age and EQ-5D index scores did not signifi-
cantly differ (p>0.05; Kruskal-Wallis test). There was no differ-
ence in BB response between groups when not watching a movie 
(p>0.05; Kruskal-Wallis test).
determining the effect of AMd severity on button response
Median (IQR) averaged BB response across all movies were: no 
AMD 0.00 (−0.03, 0.0); early AMD −0.03 (−0.04, 0); interme-
diate AMD −0.08 (−0.19,–0.02) and GA −0.07 (−0.17,–0.04). 
The average response for people with early AMD and no AMD 
differed significantly from those with intermediate AMD and 
GA (Kruskal-Wallis; p=0.04, figure 3). Median (IQR) collated 
BB response for people with intermediate AMD and GA was 
−0.07 (−0.17, –0.02) and median (IQR) BB response from 
people with no AMD or early AMD was 0.00 (−0.04, 0.00). If 
we consider the quartile of each distribution with the greatest 
BB response then the response was more than fourfold greater 
in people with intermediate AMD and GA compared with those 
with no AMD or early AMD.
Which types of mobility situations cause the greatest button 
response?
The pressure trace showing mean BB response at each time point 
across the movies for the four AMD classification groups is avail-
able in online supplementary file 1.
From our initial analysis, it was clear that people with no 
AMD and early AMD showed similar BB response, and that 
people with intermediate AMD and GA showed similar BB 
response. To simplify visualisation and analysis, we, therefore, 
generated traces grouping no AMD and early AMD together as 
‘controls’, and intermediate AMD and GA as the ‘AMD’ group 
(figure 4). Inspection of this figure shows that within certain 
movies there were specific events where BB response for people 
with AMD and controls deviated significantly (p<0.001; grey-
shaded regions of figure 4; see figure legend for details). Four 
of these events involved negotiating stairs; other events where 
these differences occurred involved avoiding cyclists on a rural 
path, flagging down a bus at night, navigating a crowd at night, 
crossing a road at night, reading a signpost with a map on it 
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Figure 4 Mean (SE) BB response (dotted line=mean; solid lines=SE) 
for the entire duration of each of the 18 movies shown. Grey regions 
on chart indicate time periods at which the difference in BB response 
between groups was significantly different (p<0.001), that is, situations 
which caused particular anxiety to individuals with dry AMD compared 
with controls. AMD, age-related macular degeneration; BB, big button; 
GA, geographic atrophy.
Figure 5 Example still shots from the movie ‘southbank’ with the corresponding pressure trace. The blue trace represents button pressure from 
people with no AMD and early AMD, and the red trace represents button pressure from people with intermediate AMD and GA. Example movies can 
be found in online supplementary files 2–4. AMD, age-related macular degeneration; GA, geographic atrophy.
and walking along a cliff path with a steep drop on one side. 
Figure 5 shows example still shots from one movie with the trace 
shown; example movies can be viewed in online supplementary 
files 2–4.
exploring potential predictors of self-perceived concern or 
anxiety related to mobility
No significant correlations were found between BB response 
and: VA (binocular, better eye and worse eye), binocular CS, 
MAIA average threshold (better eye and worse eye) or EQ-5D 
index score (Spearman’s rho; p>0.05). Scatter plots showing 
these relationships can be viewed in online supplementary file 
5. There was no difference in BB response between people who 
reported ‘no difficulty’ with mobility on EQ-5D (n=21) to those 
who reported ‘some difficulty’ (n=9) (Mann-Whitney; p>0.05). 
No participants reported extreme difficulty with mobility on 
EQ-5D.
dIsCussIon
It is well documented that people with AMD have difficulties 
with mobility. This study adds to this by exploring the effect 
dry AMD severity has on self-perceived mobility anxiety, 
and assessing predictors of this. We evaluated which types of 
mobility situations cause the greatest self-perceived anxiety for 
people with dry AMD. Our methods were novel and offer an 
important advantage over methods of assessing mobility directly 
in the real world or in a built life-like environment, such as the 
Pedestrian Accessibility and Movement Environment Labora-
tory at University College London, UK,18 and the Streetlab arti-
ficial street, Paris, France,19 in that they may be conducted in 
a safe environment, free from health and safety risks. The test 
may be presented in different ways, including through virtual/
augmented reality platforms, and on portable electronic devices. 
It also allows for the simulation of a variety of several different 
environments, that is, indoor/outdoor, rural/urban, and so on.
Our results suggest that individuals with intermediate and late 
dry AMD are more likely to experience self-perceived response 
anxiety to mobility situations than individuals with early AMD 
and those without AMD. Notably, we report increased perceived 
anxiety related to mobility in people with intermediate AMD 
(ie, large drusen, with or without pigmentary changes). This 
group is often considered to be affected minimally by AMD. For 
example, over half would meet UK vision standards for driving, 
and would certainly not be considered ‘sight-impaired’.
The greatest differences in BB response between groups was 
observed during scenes showing negotiating stairs, map reading, 
as well as walking along a cliff edge. Participants with inter-
mediate and late dry AMD consistently exhibited higher levels 
of self-perceived mobility anxiety during scenes showing stair 
negotiation, suggesting this is a particularly troublesome task. 
This worry is not unfounded; a literature review of stair negoti-
ation in ageing20 reported falls on stairs to be a leading cause of 
accidental death, that stair injuries increased with age and that 
perceived difficulty with stair negotiation is frequently reported 
among older people. These difficulties are likely exacerbated 
in AMD and several studies report alterations to movement 
and gait characteristics in AMD in an attempt (consciously or 
subconsciously) to counteract these difficulties.21 22 Three situ-
ations which caused a large difference in BB response between 
groups related to vision under low luminance. This supports the 
literature suggesting scotopic sensitivity loss and problems in 
low luminance conditions may precede other functional loss in 
AMD.23
Our results were not directly related to clinical measures of 
visual function (VA, CS and microperimetry). These results 
support those of Donoghue et al,24 who suggest that VA and CS, 
while contributing to mobility performance, do not contribute 
to fear of falling in low vision. Other measures of visual func-
tion that were not assessed may be better predictors of perceived 
mobility response anxiety. This is a limitation of our study. For 
example, earlier research has highlighted the importance of the 
photostress test and cone threshold,25 binocular central scotoma 
size,11 scanning ability26 and differential velocity threshold6 26 
in predicting mobility performance. One study27 reported the 
best predictor for self-reported mobility among people with low 
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vision to be binocular visual field, followed by scanning ability, 
low-contrast VA and finally, high-contrast VA; while another28 
reported reduced VA and CS to predict mobility restriction in 
AMD.
No relationship was found between HRQoL and BB response. 
We examined responses specifically to the EQ-5D item related 
to mobility. It was unexpected that people who reported ‘no 
difficulty’ with mobility did not differ in their BB response, 
on average, from those who reported ‘some difficulty’ with 
mobility. However, the EQ-5D item measures self-reported 
mobility difficulty, whereas the BB test measures self-reported 
mobility anxiety within specific situations. It is also possible 
that a person may report no difficulties with mobility in their 
day-to-day life because they have self-imposed mobility restric-
tions (either consciously or subconsciously), which lead to 
avoidance of anxiety-inducing situations. Previous research 
has suggested that people with vision loss from AMD do limit 
activities and mobility.3 29 The BB test may, therefore, show situ-
ations that these participants would not consider when rating 
the mobility difficulty in their day-to-day lives as these situa-
tions would normally be avoided. We did not ask participants 
about the previous history of falls; this might increase anxiety 
levels associated with mobility and we hope that future work 
will investigate this.
This study has advanced our understanding of the relation-
ship between AMD and mobility-related anxiety. However, there 
are limitations which must be acknowledged. First, it would be 
impossible to capture all possible real-world mobility scenarios 
that a person with AMD might encounter. Therefore, we have 
captured a variety of situations, including daytime and night-
time, urban and rural, and indoor and outdoor, in order to assess 
an array of potential scenarios, while keeping duration brief 
enough to maintain participants’ attention and limit fatigue. A 
second limitation relates to our setting. All participants were 
volunteers who had sufficient confidence in their own mobility 
to travel to City, University of London to participate. We, there-
fore, are likely to be underestimating the magnitude of this 
problem for the wider population of people with dry AMD. 
Future work might take a version of this test into communities 
in order to capture a wider population. Anxiety levels could be 
measured physiologically in real-time indirectly by using skin 
conductance and variations in heart or breathing rate. Skin 
conductance has been used in previous ophthalmic research 
to assess anxiety during eye examinations and contact lens 
fitting.30 31 This would have been beyond the scope of this study, 
which focused on individuals’ perceived anxiety in response to 
mobility situations, but future work could compare results from 
the BB test with measurements of anxiety using this method. 
Further investigation might link results to personality type30 and 
state and trait anxiety.31 There is some debate in the literature as 
to which type of visual field loss is more detrimental to mobility. 
Some studies (eg, Subhi et al32) report peripheral field loss to 
cause greater mobility problems, while others (eg, Turano et 
al33) report central visual field loss to be more problematic for 
mobility. This question could be addressed by replicating this 
study in people with peripheral visual field loss for comparison. 
Finally, the results presented here are limited by our sample size; 
future work ought to test this in larger numbers.
In summary, our test is a useful measure of self-perceived 
mobility anxiety for people with dry AMD. People with interme-
diate and late dry AMD are likely to experience higher levels of 
perceived concern or anxiety during everyday mobility tasks than 
people with early and without AMD. The relationship between 
mobility anxiety and other variables, such as visual function and 
psychological factors, is likely complex and requires further 
study. The BB test highlights areas of specific concern to people 
with dry AMD; negotiating stairs and vision under low lumi-
nance emerged as particularly troublesome. The test has the 
potential to be used in other eye diseases, and as a patient-cen-
tred outcome for interventions relating to mobility. The results 
have the potential to be useful in both patient management and 
educating members of the public about the real-world effects of 
AMD.
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